Cost-Method Investments

12 Months Ended

Jun. 30, 2018

(7) Cost-Method Investments

The aggregate carrying amount of our cost-method investments at June 30, 2018 and June 30, 2017, included within our other non-current assets on our consolidated balance sheets, was $41.2 million and $38.3 million, respectively.

We periodically evaluate the carrying value of our cost-method investments, when events and circumstances indicate that the carrying amount of an asset may not be recovered. We determine the fair value of our cost-method investments to evaluate whether impairment losses shall be recorded using Level 3 inputs. These investments include our holdings in privately held service and research companies that are not exchange traded and therefore not supported with observable market prices. However, these investments are valued by reference to their net asset values which can be market supported and unobservable inputs including future cash flows. We have determined that the fair value of our cost-method investments exceed their carrying values.

The following table shows a reconciliation of the changes in our cost-method investments during the years ended June 30, 2018 and June 30, 2017 (in thousands):


	Twelve Months Ended June 30,
	2018		2017
Balance at the beginning of the period	$	38,324	$	33,815
Investments		14,495		6,464
Impairment of cost-method investments		(11,593)		(1,955)
Balance at the end of the period	$	41,226	$	38,324